NeuCyte
PrivateLast Round
Grant
May 14, 2024
Total Funding Raised
$7.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeuCyte is a biotechnology company that has developed a target-identification and drug-discovery platform designed to create medicines for the treatment of neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuCyte Comparables
Compare NeuCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainXell | 86% | |
| 28bio | 86% | |
| Tempo Bioscience, Inc. | 84% |
NeuCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 14, 2024 | ||||
| Grant | Aug 14, 2023 | ||||
| Series A | May 8, 2018 |
NeuCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Leaguer Tsing-Yuan Venture Capital Management | Series A |
| Co-Win Ventures | Series A |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 21, representing 191% of headcount.
- Jan 25, 2025
Monthly visitors increased 38% MoM, reaching 2.2K.
NeuCyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeuCyte's valuation, stock price, and market status.
Is NeuCyte a public or private company?
NeuCyte is a private company.
What is the current stock price of NeuCyte?
NeuCyte is a private company with no public stock price. No recent secondary market data is available.
How much is NeuCyte worth (valuation)?
Valuation information for NeuCyte is not publicly available.
Can I buy NeuCyte stock?
NeuCyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeuCyte's last funding round?
NeuCyte's most recent funding round was Grant on May 14, 2024.
Who are the main investors in NeuCyte?
Key investors in NeuCyte include Shenzhen Leaguer Tsing-Yuan Venture Capital Management, Co-Win Ventures.
Will NeuCyte IPO soon?
No public IPO plans have been announced for NeuCyte.
How can I track NeuCyte secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuCyte's secondary market activity and sign up for updates.